Healthcare & Life Sciences
Replay Holdings
About
Replay Holdings develops a platform to deliver large DNA payloads efficiently to any cell type, featuring a high-capacity HSV vector for gene delivery and a hypoimmunogenic iPSC therapeutic platform targeting the cell and gene therapy market.
Explore Replay Holdings's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.